Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Vanessa](/img/uploaded/aab593d7615a80d42da1c23d7d2bc16b.jpeg)
![Foto de Hospital General Universitario de Alicante](/img/noimage_org.png)
Hospital General Universitario de Alicante
Alicante, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (78)
2022
-
Current trends on antithrombotic therapy
REC: CardioClinics
2020
-
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 9, pp. 749-757
2019
-
Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency
Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418
2018
-
Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers
Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
2017
-
Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa
Emergencias, Vol. 29, Núm. 1, pp. 18-26
-
Evaluación de los esquemas de riesgo hemorrágico HAS-BLED y ORBIT en pacientes con fibrilación auricular no valvular tratados con anticoagulación oral
Revista Espanola de Cardiologia
-
Strategies for prediction and early detection of atrial fibrillation: Present and future
Europace
2016
-
Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?
Circulation Journal, Vol. 80, Núm. 10, pp. 2102-2108
-
Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion
Circulation Journal, Vol. 80, Núm. 3, pp. 605-612
2015
-
Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state
Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617
2013
-
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
Age and Ageing, Vol. 42, Núm. 1, pp. 70-75
2012
-
Prognostic value of mean platelet volume in patients with non-ST-elevation acute coronary syndrome
Angiology
-
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Circulation: Cardiovascular Interventions, Vol. 5, Núm. 4, pp. 459-466
2011
-
An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization
Chest, Vol. 139, Núm. 6, pp. 1402-1409
-
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study
Thrombosis Research
2010
-
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease
International Journal of Cardiology, Vol. 139, Núm. 1, pp. 95-97
-
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction
Thrombosis and Haemostasis
-
The prognostic value of biomarkers after a premature myocardial infarction
International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254
2009
-
Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis
Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486